POST-ACUTE COVID-19 SYNDROME
Clinical trials for POST-ACUTE COVID-19 SYNDROME explained in plain language.
Never miss a new study
Get alerted when new POST-ACUTE COVID-19 SYNDROME trials appear
Sign up with your email to follow new studies for POST-ACUTE COVID-19 SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug tested to fight long COVID's brain fog and fatigue
Disease control Not yet recruitingThis early-stage study is testing whether a single dose of pembrolizumab, a drug used for cancer, is safe for people with long-term neurological symptoms after COVID-19. Researchers want to see if the drug can help reset the immune system and improve symptoms like fatigue, thinki…
Matched conditions: POST-ACUTE COVID-19 SYNDROME
Phase: PHASE1 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Hope for spanish speakers battling long COVID: new therapy program launches
Symptom relief Not yet recruitingThis study is testing a Spanish-language version of a 12-week online group therapy program designed for people living with Long COVID. The program aims to help participants build resilience, learn coping skills, and improve their quality of life. Researchers will enroll 25 Spanis…
Matched conditions: POST-ACUTE COVID-19 SYNDROME
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC
-
Scientists map the 'Breathing Scars' of long COVID
Knowledge-focused Not yet recruitingThis study aims to better understand how COVID-19 affects lung function in the long term. Researchers will compare detailed CT scans of the lungs with a special, non-invasive breathing test called electrical impedance tomography in 50 adults with ongoing post-COVID symptoms. The …
Matched conditions: POST-ACUTE COVID-19 SYNDROME
Sponsor: Jan-Christoph Lewejohann • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:55 UTC